• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911420270
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiomyopathy (1764); Death (1802); Heart Failure (2206)
Event Date 08/21/2017
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is anticipated procedural complication as the reported event is due to a known physiological effect of the procedure noted within the product directions for use (dfu) and/or device labeling.(b)(4).
 
Event Description
(b)(6) study; it was reported that following a coronary artery drug eluting stenting treatment procedure, the patient had biventricular heart failure and expired.In (b)(6) 2012, the patient presented due to unstable angina (braunwald classification: iiib) and was referred for cardiac catheterization.The de novo target lesion was located in the mid left anterior descending artery (mid lad) with 70% stenosis and was 20mm long with a reference vessel diameter of 2.75mm.The target lesion was treated with pre-dilation and placement of a 2.75x20mm promus element plus stent, with 0% residual stenosis following post-dilation.The patient was discharged on aspirin the next day.In (b)(6) 2017, the patient expired.Per death certificate, the primary and immediate cause of death was ¿biventricular heart failure secondary to ischemic cardiomyopathy¿.It was confirmed that no autopsy was performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6892993
MDR Text Key87293057
Report Number2134265-2017-09244
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729807902
UDI-Public08714729807902
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/12/2012
Device Model NumberH7493911420270
Device Catalogue Number39114-2027
Device Lot Number0014960489
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/29/2017
Initial Date FDA Received09/26/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/28/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age68 YR
-
-